In March 2025, the company announced new programs for a direct-to-consumer featuring of its Wegovy weight loss drug. The company proven a completely new pharmacy, termed NovoCare, which might cost clients $499 each month for access to the drug, below 50 % the cost of the drug as a result of other pharmaceutical distribution networks.[fifty three]Th